ReNeuron said the results provided 'clear pre-clinical proof-of-concept' that its exosome technology can deliver therapeutic proteins to the region of the brain affected by disabling neurological diseases.
from Home | Mail Online https://ift.tt/3aocGeH
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment